Abattis Bioceuticals Corp. (ATTBF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|
| Revenue | 356.87 Thousand | 8371.00 | - | - | 91.94 Thousand | 7720.00 |
| Cost of Revenue | 115.54 Thousand | 1894.00 | - | - | 29.31 Thousand | - |
| Gross Profit | 241.33 Thousand | 6477.00 | - | - | 62.62 Thousand | 7720.00 |
| Operating Expenses | 4.25 Million | 15.83 Million | 6.36 Million | 2.3 Million | 3.14 Million | 7.36 Million |
| Selling, General and Administrative Expenses | 4.14 Million | 15.77 Million | 6.21 Million | 2.13 Million | 2.87 Million | 7.13 Million |
| Research and Development Expenses | - | 28.88 Thousand | 24.69 Thousand | 40.01 Thousand | 82.79 Thousand | 129.05 Thousand |
| Other Expenses | 58.16 Thousand | -672.28 Thousand | 2900.00 | - | - | - |
| Cost and Expenses | 4.37 Million | 15.83 Million | 6.36 Million | 2.3 Million | 3.16 Million | 7.36 Million |
| Operating Income | -3.95 Million | -17.37 Million | -6.36 Million | -2.3 Million | -3.07 Million | -7.35 Million |
| Interest Expense | 49.36 Thousand | 4.33 Million | 3041.00 | 29.84 Thousand | 18.69 Thousand | 137.49 Thousand |
| Income Tax Expense | 88.52 Thousand | 3.15 Million | -286.11 Thousand | -42.91 Thousand | -419.29 Thousand | -39.86 Thousand |
| Earnings before Tax | -3.06 Million | -77.65 Million | -7.92 Million | -2.41 Million | -5.99 Million | -7.65 Million |
| Net Income | -3.04 Million | -78.01 Million | -7.63 Million | -2.33 Million | -4.47 Million | -7.56 Million |
| Earnings Per Share Basic | -0.01 | -0.24 | -0.05 | -0.02 | -0.06 | -0.16 |
| Earnings Per Share Diluted | -0.01 | -0.24 | -0.05 | -0.02 | -0.06 | -0.16 |
| Weighted Average Shares Outstanding | 470.49 Million | 322.64 Million | 148.66 Million | 94.99 Million | 68.81 Million | 48.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 470.49 Million | 322.64 Million | 148.66 Million | 94.99 Million | 68.81 Million | 48.8 Million |
| Gross Margin | 0.68 | 0.77 | - | - | 0.68 | 1.00 |
| EBIT Margin | -10.78 | -2070.96 | - | - | -34.49 | -941.16 |
| Profit Margin | -8.52 | -9319.40 | - | - | -48.65 | -980.49 |
| EBITDA | -3.84 Million | -17.33 Million | -5.33 Million | -2.13 Million | -3.17 Million | -7.26 Million |
| Earnings Before Tax Margin | -11.09 | -2075.42 | - | - | -33.48 | -952.93 |
| Breakdown | 2019 FY | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 FY |
|---|---|---|---|---|---|---|
| Revenue | 356.87 Thousand | 226.26 Thousand | 127.79 Thousand | 2174.00 | 643.00 | 8371.00 |
| Cost of Revenue | 115.54 Thousand | 64.13 Thousand | 51.4 Thousand | - | - | 1894.00 |
| Gross Profit | 241.33 Thousand | 162.13 Thousand | 76.38 Thousand | 2174.00 | 643.00 | 6477.00 |
| Operating Expenses | 4.25 Million | 684.23 Thousand | 866.81 Thousand | 1.05 Million | 1.64 Million | 15.83 Million |
| Selling, General and Administrative Expenses | - | 637.82 Thousand | 845.56 Thousand | 1.03 Million | 1.62 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 58.16 Thousand | 52 Thousand | - | 6110.00 | 43.84 Thousand | -672.28 Thousand |
| Cost and Expenses | 4.37 Million | 748.36 Thousand | 918.21 Thousand | 1.05 Million | 1.64 Million | 15.83 Million |
| Operating Income | -3.95 Million | -470.09 Thousand | -790.42 Thousand | -1.05 Million | -1.6 Million | -17.37 Million |
| Interest Expense | 49.36 Thousand | 42.86 Thousand | 3202.00 | - | 2347.00 | 4.33 Million |
| Income Tax Expense | 88.52 Thousand | 70.74 Thousand | 5127.00 | 6110.00 | 46.19 Thousand | 3.15 Million |
| Earnings before Tax | -3.06 Million | -931.18 Thousand | -730.53 Thousand | -142.54 Thousand | -1.25 Million | -77.65 Million |
| Net Income | -3.04 Million | -907.05 Thousand | -735.65 Thousand | -142.54 Thousand | -1.25 Million | -78.01 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 470.49 Million | 477.88 Million | 477.8 Million | 477.64 Million | 448.95 Million | 322.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 470.49 Million | 477.88 Million | 477.8 Million | 477.64 Million | 448.95 Million | 322.64 Million |
| Gross Margin | 0.68 | 0.72 | 0.60 | 1.00 | 1.00 | 0.77 |
| EBIT Margin | - | -1.87 | -6.02 | -474.04 | -2459.59 | - |
| Profit Margin | -8.52 | -4.01 | -5.76 | -65.57 | -1954.50 | -9319.40 |
| EBITDA | - | -423.69 Thousand | -769.17 Thousand | -1.03 Million | -1.58 Million | - |
| Earnings Before Tax Margin | -11.09 | -2.08 | -6.19 | -483.74 | -2491.11 | -2075.42 |
ENTI
1606
2B4
MSDL
7678
PHYOF